Inherited genetic variation and overall survival following follicular lymphoma

American Journal of Hematology

Volumn 87, Issue 7, 2012, Pages 724-726

  Gibson, Todd M ^a   Wang, Sophia S ^b   Cerhan, James R ^c   Maurer, Matthew J ^c   Hartge, Patricia ^a   Habermann, Thomas M ^c   Davis, Scott ^d,e   Cozen, Wendy ^f   Lynch, Charles F ^g   Severson, Richard K ^h,i   Rothman, Nathaniel ^a   Chanock, Stephen J ^a   Morton, Lindsay M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c Mayo Clinic College of Medicine   (United States)

^d USA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h WAYNE STATE UNIVERSITY   (United States)

ⁱ KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM17 PROTEIN; DUAL SPECIFICITY PHOSPHATASE 2; MEMBRANE PROTEIN; OSTEOGENIC PROTEIN 1; PROTEIN GADD45B; PROTEIN GALNT 12; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; AGED; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER REGISTRY; CASE CONTROL STUDY; CAUSE OF DEATH; CONTROLLED STUDY; DRUG DOSE REGIMEN; ETHNICITY; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GENE IDENTIFICATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; INHERITANCE; LETTER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84862550386     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23184     Document Type: Letter

References (27)

1. Friedberg JW. Treatment of follicular non-Hodgkin's lymphoma: The old and the new. Semin Hematol 2008; 45: S2-S6.
2. Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265-276.
3. Johnson PW, Rohatiner AZ, Whelan JS, et al. Patterns of survival in patients with recurrent follicular lymphoma: A 20-year study from a single center. J Clin Oncol 1995; 13: 140-147.
4. Al-Tourah AJ, Gill KK, Chhanabhai M, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. J Clin Oncol 2008; 26: 5165-5169.
5. Federico M, Bellei M, Marcheselli L, et al. Follicular lymphoma international prognostic index 2: A new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 2009; 27: 4555-4562.
6. Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258-1265.
7. Fisher RI, LeBlanc M, Press OW, et al. New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 2005; 23: 8447-8452.
8. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159-2169.
9. de Jong D. Molecular pathogenesis of follicular lymphoma: A cross talk of genetic and immunologic factors. J Clin Oncol 2005; 23: 6358-6363.
10. Cerhan JR, Wang S, Maurer MJ, et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 2007; 109: 5439-5446.
11. Wang SS, Maurer MJ, Morton LM, et al. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Leukemia 2009; 23: 596-602.
12. Gentles AJ, Alizadeh AA, Lee SI, et al. A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients. Blood 2009; 114: 3158-3166.
13. Shaffer AL, Wright G, Yang L, et al. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev 2006; 210: 67-85.
14. Bea S, Zettl A, Wright G, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 2005; 106: 3183-3190.
15. Rudd MF, Sellick GS, Webb EL, et al. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood 2006; 108: 638-644.
16. Cassar L, Li H, Pinto AR, et al. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. Cancer Res 2008; 68: 9157-9166.
17. Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci 2007; 98: 621-628.
18. Engelmann A, Speidel D, Bornkamm GW, et al. Gadd45 beta is a pro-survival factor associated with stress-resistant tumors. Oncogene 2008; 27: 1429-1438.
19. Bermudez O, Pages G, Gimond C. The dual-specificity MAP kinase phosphatases: Critical roles in development and cancer. Am J Physiol Cell Physiol 2010; 299: C189-C202.
20. Guda K, Moinova H, He J, et al. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers. Proc Natl Acad Sci USA 2009; 106: 12921-12925.
21. Brockhausen I. Mucin-type O-glycans in human colon and breast cancer: Glycodynamics and functions. EMBO Rep 2006; 7: 599-604.
22. Friedberg JW, Taylor MD, Cerhan JR, et al. Follicular lymphoma in the United States: First report of the national LymphoCare study. J Clin Oncol 2009; 27: 1202-1208.
23. Wang SS, Menashe I, Cerhan JR, et al. Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2011; 20: 42-49.
24. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization; 2000.
25. Bhatti P, Sigurdson AJ, Wang SS, et al. Genetic variation and willingness to participate in epidemiologic research: Data from three studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 2449-2453.
26. Gauderman WJ, Murcray C, Gilliland F, Conti DV. Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 2007; 31: 383-395.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate-A practical and powerful approach to multiple testing. J R Stat Soc B Met 1995; 57: 289-300.